Vaishali Pharma Limited

Vaishali Pharma Limited (VAISHALI) is a micro-cap Healthcare company valued at ₹105 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Vaishali Pharma Limited last traded at ₹7.8, modestly up 0.13% on the day.

Recent developments

On 2026-07-31, promoter holding was reported at 30.54%, showing no change from the previous quarter. The company has not paid any dividends despite reporting profits, which may indicate a focus on reinvestment or liquidity management.

Financial performance

The company's business has improved significantly, with annual net profit rising 407.3% to ₹4 crore, driven by a sharp increase in the net profit margin to 3.8% from 0.8%. However, the latest quarter showed a decline in revenue of 3.6% compared to the same quarter a year earlier, while net profit rose 21.1%.

Valuation multiples

The stock trades at 24.4 times earnings, a discount to the Healthcare median of 32.0, 1.62 times book value.

Things to watch

The company's profit growth has slowed in recent years, with a 14.3% annual decline in profit over the past three years. The stock is 29.5% below its 52-week high, and the company has not distributed any dividends to shareholders despite reporting profits.

Where it stands

Vaishali Pharma Limited has seen a sharp rise in net profit margins and annual net profit, but recent quarterly performance shows a decline in revenue. The stock is trading below its 52-week high, and the company has not paid dividends despite profitability.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.